Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $122.63 USD
Change Today -2.45 / -1.96%
Volume 1.1M
VRTX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
As of 8:10 PM 05/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeffrey M. Leiden M.D., Ph.D.

Chairman, Chief Executive Officer and President, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 138 board members in 6 different organizations across 10 different industries.

See Board Relationships
58$36,635,468
As of Fiscal Year 2014

Background*

Dr. Jeffrey M. Leiden, M.D., Ph.D., has been the Chief Executive Officer and President of Vertex Pharmaceuticals Incorporated since February 1, 2012. Dr. Leiden serves as a Senior Advisor at Clarus Ventures, LLC. He has more than 20 years of experience in the biomedical and pharmaceutical sectors. He served as Managing Director of Clarus Ventures since 2007, which he joined in 2006. He joined Clarus Ventures in November 1, 2006 as a Partner. He served as the President ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

Director
Member of Executive Committee of Board of Trustees
Trustee
Trustee
Former Chairman
Former Chairman
1999-2006
Former President of Pharmaceutical Products Group, Chief Operating Officer of Pharmaceutical Products Group and Director
2007-N/A
Former Independent Director and Member of Research & Development Committee
2007-2012
Former Vice Chairman, Chairman of Science & Technology Committee, Member of Nomination Committee and Member of Remuneration Committee
2008-N/A
Director
2008-N/A
Former Chairman, Member of Audit Committee and Member of Compensation Committee
2009-Present
Chairman, Chief Executive Officer and President
2014-Present
Director and Member of Compensation Committee
2015-Present
Director

Education*

MA
Harvard University
PhD
The University of Chicago
BA
The University of Chicago
MD
The University of Chicago

Other Affiliations*

Annual Compensation*

Salary$1,100,000
Total Annual Compensation$1,100,000

Stock Options*

Restricted Stock Awards$19,883,350
All Other Compensation$12,857
Exercised Options245,000
Exercised Options Value$18,793,100
Exercisable Options396,294
Exercisable Options Value$27,918,929
Unexercisable Options611,841
Unexercisable Options Value$33,090,777
Total Value of Options$79,802,806
Total Number of Options1,253,135

Total Compensation*

Total Annual Cash Compensation$4,082,857
Total Short Term Compensation$1,100,000
Other Long Term Compensation$19,896,207
Total Calculated Compensation$36,635,468
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $122.63 USD -2.45

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$916.0K
Robert W. Duggan Chairman and Chief Executive Officer
Pharmacyclics Inc.
--
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.